Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

NCT01168921 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

CLL
Leukemia

Interventions

DRUG: Eltrombopag

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]